PortalPortal HypertensionHypertension andand itsits ComplicationsComplications
TomTom FrazierFrazier WhatWhat II’’mm GonnaGonna TellTell YouYou
Pathophysiology of Portal HTN and its Complications Review diagnostic concerns and management of… Ascites Gastric and esophageal varices HRS HPS Hepatic encephalopathy
J Physiol Pharmacol. 2008 Aug;59 Suppl 2:231-8 WhatWhat II expectexpect youyou toto rememberremember
GeneralGeneral PathophysPathophys ofof portalportal htnhtn,, he,he, varices,varices, hrshrs WhereWhere toto findfind answersanswers whenwhen theythey comecome upup HEHE treatmenttreatment andand problemsproblems withwith ourour curentcurent assumptionsassumptions PathogenesisPathogenesis ofof PortalPortal Hypertension:Hypertension: HemodynamicHemodynamic FactorsFactors
Cirrhosis most common etiology portal pressure gradient > 5 mm Hg Hallmark is a pathologic increase in the pressure gradient between the portal vein and the inferior vena cava, which is measured by the hepatic venous pressure gradient (HVPG) HVPG = WHVP – FHVP Ohm's law: P= Q (blood flow) x R Two steps Decreased outflow Increased inflow ClassificationClassification ofof portalportal hypertensionhypertension StepStep 1:1: IncreasedIncreased outflowoutflow resistanceresistance
ThisThis resultsresults fromfrom 22 factors:factors: (1)(1) mechanicalmechanical obstructionobstruction toto flowflow becausebecause ofof fibroticfibrotic disruptiondisruption ofof architecturearchitecture (2)(2) aa dynamicdynamic componentcomponent producedproduced byby activeactive contractioncontraction ofof vascularvascular smoothsmooth musclemuscle cellscells andand activatedactivated stellatestellate cellscells TheThe dynamicdynamic componentcomponent accountsaccounts forfor approximatelyapproximately 30%30% ofof thethe intrahepaticintrahepatic resistanceresistance inin cirrhosiscirrhosis StepStep 1:1: TheThe DYNAMICDYNAMIC componentcomponent
Intrahepatic ↓(eNOS) activity and NO production. impaired Akt-mediated eNOS phosphorylation (which is partially reversible by statins) increased caveolin expression (particularly if folate deficiency exists). nitrosylation reactions secondary to oxidative stress (↓NO) and vasoconstriction mediated by endothelin, angiotensinogen, and eicosanoids. other vasoactive mediators such as carbon monoxide, adrenergic tone, endotoxemia, and inflammatory cytokines StepStep 2:2: IncreasedIncreased PortalPortal VenousVenous InflowInflow
Mesenteric arterial vasodilation ↑ portal venous inflow systemic hyperdynamic circulatory state (↓ svr and map with ↑ CO). Caused by ↑ NO Shear stress, ↑ VEGF, and TNF-α are causes of ↑ splanchnic NO production in cirrhosis ↑ heme oxygenase activity and CO production may also contribute Bacteremia can ↑ vasodilation by stimulating TNF-α production and activation of endocannabinoids, which are potent vasodilators. Blockade of VEGF signaling attenuates the increase in portal venous inflow seen in cirrhosis PortalPortal HTNHTN andand itsits ComplicationsComplications
CO fails to compensate overtime
Clinics in Liver Disease - Volume 9, Issue 4 (November 2005) AcitesAcites FormationFormation
IncreasedIncreased hepatichepatic sinusoidalsinusoidal pressurepressure ThreeThree interrelatedinterrelated pathophysiologicpathophysiologic processesprocesses contributecontribute toto thethe developmentdevelopment ofof ascites.ascites. systemicsystemic arteriolararteriolar vasodilation,vasodilation, activationactivation ofof NaNa andand H2OH2O retention,retention, sinusoidalsinusoidal portalportal hypertension.hypertensi